Patent · US Active

Amnion derived adherent cells

US8367409B2 · kind B2 · utility

25Cited by

148References

14Claims

0Family size

Assignee

Anthrogenesis Corporation · US

Inventors

Stewart Abbot · Hackettstown, US
James W. Edinger · Belford, US
Aleksandar Francki · Santa Monica, US
Aleksandr Kaplunovsky · Budd Lake, US
Vladimir Jankovic · New York, US
Kristen Labazzo · Springfield, US
Eric Law · Florham Park, US
Neerav D. PADLIYA · Scotch Plains, US
Jennifer Paredes · Florham Park, US
Jia-Lun Wang · Cherry Hill, US

Key dates

Filing date	Nov 19, 2009
Grant date	Feb 5, 2013
Priority date	—
Expiry date	Oct 16, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K35/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.